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Objective: von Willebrand factor (vWF) is essential for the formation of platelet aggregates at sites of vascular endothelial
cell (EC) injury. Peri-operative thrombocytopenia is associated with poor outcome in ruptured abdominal aortic aneurysm
(AAA) repair. This prospective study examines the relationship between vWF and platelet count (PC) in ruptured AAA
repair.
Methods: plasma vWF antigen, PC and C-reactive protein (CRP) were measured pre-operatively, and immediately before
and 5 min after aortic clamp release, and on post-operative days 1 and 2 in 20 patients (18 men and 2 women of median age
74, range 63–86, years) with ruptured AAA.
Results: elevated vWF was present in 13 (65%) patients pre-operatively, and 14 of 16 (88%) survivors at 24 h post-
operatively. All patients demonstrated an intra-operative fall in vWF. There was no significant difference in vWF levels
between survivors and non-survivors. PC was below the normal range in 8 (40%) patients pre-operatively and all patients at
24 h. Eighteen (90%) patients demonstrated an intro-operative fall in PC. PC was significantly lower in non-survivors pre-
operatively (p ¼ 0.007), immediately before (p ¼ 0.009) and 5 min (p ¼ 0.009) and 24 h (p ¼ 0.02) after clamp release.
There was a significant positive correlation between vWF and PC pre-operatively (r ¼ þ0.48, p ¼ 0.033), and immediately
before (r ¼ þ0.47, p ¼ 0.044) and 5 min after clamp release (r ¼ þ0.5, p ¼ 0.043). There was a significant positive
correlation between peak vWF level and the greatest fall in PC (r ¼ þ0.65, p ¼ 0.006). There was a significant negative
correlation between vWF and CRP and operative blood loss; and between PC and CRP, operative blood loss and aortic clamp
time.
Conclusions: these data demonstrate that EC activation, the acute phase protein response, operative blood loss and aortic
clamp time all contribute to the peri-operative fall in PC in patients with ruptured AAA. The peri-operative fall in
circulating levels of vWF and PC may represent consumption secondary to macro- and microvascular thrombus formation.
The resultant procoagulant state may partly explain the association between low PC and poor outcome in ruptured AAA.
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Introduction
Endothelial cell (EC) injury leads to the expression of
tissue factor which triggers the extrinsic coagulation
cascade and leads to thrombin generation. Previous
work from this department has demonstrated that
ruptured infrarenal abdominal aortic aneurysm
(AAA) repair is associated with increased thrombin
generation which occurs as part of a generalised pro-
coagulant state.1 As well as initiating coagulation, EC
activation and injury stimulate the rapid release of von
Willebrand factor (vWF) into the circulation. vWF
binds to exposed subendothelial collagen and elastin
at sites of vessel injury, and platelets then irreversibly
bind to vWF. Plasma vWF,2 almost all of which is
derived from endothelium,3,4 accounts for 60% of total
platelet adhesion, with the remaining 40% provided
by endothelial cell vWF.2 vWF is essential for the
formation of platelet aggregates at sites of arterial
injury.5 Previous work has demonstrated that rup-
tured AAA repair is associated with early peri-
operative thrombocytopenia.6,7 Furthermore, a strong
association exists between platelet count (PC) and
mortality, multiple organ failure (MOF) and thrombo-
embolic events.6 Although the underlying mechan-
isms remain ill-defined, vWF and its effect on platelets
may have an important role in the procoagulant state
which occurs in patients undergoing ruptured AAA
repair. To date, there have been few studies examining
vWF in patients undergoing elective aortic surgery,8,9
and none in patients with ruptured AAA. This study
Eur J Vasc Endovasc Surg 26, 412–417 (2003)
doi: 10.1016/S1078-5884(03)00013-3, available online at http://www.sciencedirect.com on
*Corresponding author: A. W. Bradbury, University Department of
Vascular Surgery, Research Institute (Lincoln House), Heartlands
Hospital, Bordesley Green East, Birmingham B9 5SS, U. K..
1078–5884/000412 + 06 $35.00/0 q 2003 Elsevier Ltd. All rights reserved.
examines serial peri-operative changes in vWF and PC
in patients operated upon for ruptured AAA.
Methods
Patients
Twenty patients (18 men and 2 women of median age
74, range 63–86, years) operated for ruptured infra-
renal AAA were prospectively studied. Co-morbidity
data are shown in Table 1. The median (range) delay
between the onset of symptoms of rupture and
hospital admission was 5 (2–14) h. All patients had
at least one documented episode of hypotension
(systolic blood pressure less than 100 mmHg) prior
to surgery. Pre-operatively, the median (range) per-
ipheral body temperature was 35.4 (32.2–37.5) 8C.
Operative methods
Ruptured AAA was defined by the presence of fresh
retroperitoneal and/or intraperitoneal blood in the
presence of an aortic aneurysm with no other
identifiable cause for the findings at operation. All
patients underwent AAA repair under general anaes-
thesia using a transverse supra-umbilical incision with
infra-renal aortic cross-clamping. No patients were
systemically heparinised. Rupture was retroperitoneal
in 14 patients and intraperitoneal in six. A dacron
aorto-aortic graft was inserted in 13 patients, aorto-bi-
iliac graft in two and aorto-bifemoral graft in three
patients. Two patients had no graft inserted.
Blood sample collection
Arterial blood was sampled from an indwelling radial
arterial line immediately prior to the induction of
anaesthesia (sample A); immediately before release of
the aortic clamp (sample B); 5 min (sample C) and 24
(sample D) and 48 h (sample E) after aortic clamp
release. The first 10 ml of blood were discarded. Blood
was collected in a standard syringe without the
application of suction, and then transferred to specific
tubes. A 2.7 ml sample was collected into EDTA
anticoagulant (1.6 mg/ml), a 3 ml sample was col-
lected into sodium citrate anticoagulant (0.106 mol/l)
and a 9 ml sample was collected into clot activator.
Samples were placed immediately on ice and trans-
ferred to the laboratory where they were centrifuged
within 30 min of collection at 3000 revolutions per
minute for 30 min at a temperature of 4 8C (1400 g).
Plasma and serum were separated and stored at
270 8C for later batch analysis.
Haemostatic and endothelial markers and C-reactive protein
Haematocrit (normal range, 0.37–0.54) and whole
blood PC (normal range, 150 – 350 £ 109/l) were
determined on an EDTA sample using the fully-
automated Sysmex NE 8000 analyser. vWF antigen
(normal range, 0.42–1.22 IU/ml) was determined on a
sodium citrate sample by enzyme linked immunosor-
bent assay (ELISA). Serum C-reactive protein (CRP)
(normal range, ,10 mg/l) (DAKO, Denmark) was
determined by ELISA.
Statistical analysis
The Mann–Whitney U-test was used to compare
groups of patients. As the data were not normally
distributed, the Spearman rank correlation was used
to correlate clinicopathological variables and haemo-
static data. A probability value of less than 0.05 was
regarded as statistically significant.
Table 1. Co-morbidity of 20 patients with ruptured infrarenal
abdominal aortic aneurysm.
Number of patients
Co-morbidity
None 5
Myocardial infarction 3
Angina pectoris 4
Coronary artery bypass graft –
Hypertension 7
Congestive cardiac failure 1
Atrial fibrillation 1
Stroke 2
Peripheral arterial occlusive disease 1
Venous thrombo-embolism –
Chronic obstructive airways disease 2
Non-insulin dependent diabetes mellitus –
Cigarette smoking
Non-smoker 11
Ex-smoker 4
Current smoker 5
Medications
None 7
Aspirin 7
Diuretic 6
Nitrate 2
Angiotensin converting enzyme inhibitor 1
Calcium-channel blocker 1
Beta-adrenoceptor blocker –
Bronchodilator 2
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Results
Clinical data
Clinical and operative data are summarized in Table 2.
There was no significant difference in aortic clamp
time, operative blood loss, or volume of red cell
concentrate (RCC), fresh frozen plasma (FFP) or
platelet transfusion between survivors and non-
survivors. Nine patients with ruptured AAA died;
three during attempted repair (two of whom had no
graft inserted), one in the recovery room immediately
after graft insertion, and five in the post-operative
period. Fifteen of 16 patients who survived to at least
24 h developed major complications (Table 3).
Haemostatic and endothelial cell markers
The values of haemostatic and endothelial markers
and CRP are shown in Table 4. vWF was elevated
above the normal reference range in 13 of 20 (65%)
patients pre-operatively and 14 of 16 (88%) patients at
24 h post-operatively. All of the patients demonstrated
an intra-operative call in vWF. There was no signifi-
cant difference in vWF levels between survivors and
non-survivors. PC was below the normal reference
range in 8 of 20 (40%) patients pre-operatively and all
patients at 24 h. Eighteen of 20 (90%) patients demon-
strated an intra-operative fall in PC. PC was signifi-
cantly lower in non-survivors compared with
survivors pre-operatively ðp ¼ 0:007Þ; immediately
before ðp ¼ 0:009Þ and 5 min ðp ¼ 0:009Þ and 24 h ðp ¼
0:02Þ after clamp release.
There was a significant positive correlation between
vWF and PC pre-operatively (r ¼ þ0:48; p ¼ 0:033)
(Fig. 1), immediately before (r ¼ þ0:47; p ¼ 0:044) (Fig.
2) and 5 min after clamp release (r ¼ þ0:52; p ¼ 0:04)
(Fig. 3). The relationship between vWF and PC pre-
operatively (r ¼ þ0:55; p ¼ 0:028), immediately before
(r ¼ þ0:56; p ¼ 0:038) and 5 min after clamp release
(r ¼ þ0:58; p ¼ 0:029) was more significant in those
patients who survived to at least 24 h. There was a
significant positive correlation between the greatest
fall in vWF and the greatest fall in PC during the first
48 h (r ¼ þ0:63; p ¼ 0:009). There was also a significant
positive correlation between peak vWF level and the
greatest fall in PC both peri-operatively (r ¼ þ0:63;
p ¼ 0:012) and during the first 48 h (r ¼ þ0:65;
p ¼ 0:006).
There was no significant relationship between
duration of symptoms of rupture, pre-operative body
temperature or haematocrit and vWF or PC. There was
a significant negative correlation between CRP at 24 h
post-operatively and vWF pre-operatively (r ¼ 20:59;
p ¼ 0:015), and PC pre-operatively (r ¼ 20:55;
p ¼ 0:027), immediately before (r ¼ 20:66; p ¼ 0:011)
and 5 min after aortic clamp release (r ¼ 20:55;
p ¼ 0:041). There was a significant negative correlation
between operative blood loss and vWF 5 min after
aortic clamp release in all patients (r ¼ 20:53;
p ¼ 0:03) and this was more significant in those
patients who survived to at least 24 h (r ¼ 20:66;
p ¼ 0:007). There was a significant negative correlation
between operative blood loss and PC 5 min after
clamp release in all patients (r ¼ 20:57; p ¼ 0:027) and
this was also more significant in those patients who
survived to at least 24 h (r ¼ 20:62; p ¼ 0:023). There
was a significant negative correlation between aortic
clamp time and PC 5 min after clamp release in all
patients (r ¼ 20:57; p ¼ 0:02).
Table 2. Clinical and operative data of 20 patients with ruptured
infrarenal abdominal aortic aneurysm.
Median (range)
Pre-operative
Serum creatinine (mmol/l) 129 (77–233)
Crystalloid and colloid administration (1) 0.7 (0.1–5.5)
Intra-operative
Aortic clamp time (min) 70 (30–150)
Measured blood loss (l) 4.0 (1.0–11.0)
Crystalloid and colloid administration (l) 3.5 (1.5–12.5)
RCC administration (units) 8 (5–22)
FFP administration (units) 2 (0–12)
Platelet administration (bags) 1 (0–2)1
Post-operative
Duration of ITU stay (h) 73 (13–579)
Duration of IPPV (h) 22 (9–451)
Duration of hospital stay (days) 19 (9–50)
RCC ¼ red cell concentrate, FFP ¼ fresh frozen plasma, ITU ¼
intensive therapy unit, IPPV ¼ intermittent positive pressure
ventilation.
1 ¼ 17 patients received intra-operative platelet transfusion and a
further three received 1, 2 and 2 units of platelets post-operatively.
Table 3. Post-operative complications and procedures in 16
patients who survived to at least 24 h.
Number of patients
Cardiovascular
Atrial fibrillation 6
Cardiac failure 7
Myocardial infarction 2
Stroke 3
Critical limb ischaemia 3
Deep venous thrombosis 2
Respiratory
Chest infection 11
Respiratory failure 7
Acute renal failure 8
Coagulopathy 3
Sepsis syndrome 3
Colon ischaemia 1
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Table 4. Haemostatic markers, endothelial cell markers and C-reactive protein in 20 patients with ruptured infrarenal abdominal aortic aneurysm.
Assay (normal range) Sample point Median (range) p*
All patients Survivors
Samples A–E, n ¼ 11
Non-survivors
Samples A þ B, n ¼ 9
Sample C, n ¼ 7
Samples D þ E, n ¼ 5
Haematocrit (0.37–0.54) A 0.31 (0.13–0.45) 0.32 (0.13–0.45) 0.27 (0.14–0.34) NS
B 0.29 (0.18–0.44) 0.31 (0.18–0.44) 0.26 (0.2–0.38) NS
C 0.27 (0.18–0.42) 0.32 (0.23–0.42) 0.24 (0.18–0.33) NS
D 0.33 (0.25–0.42) 0.33 (0.26–0.42) 0.33 (0.27–0.35) NS
E 0.31 (0.24–0.41) 0.32 (0.24–0.41) 0.31 (0.26–0.36) NS
Platelet count A 182 (40–321) 224 (144–303) 119 (40–321) 0.007
(150–350 £ 109/l) B 110 (48–189) 123 (86–189) 81 (48–116) 0.009
C 93 (44–146) 114 (59–146) 74 (44–93) 0.009
D 97 (23–133) 102 (50–133) 72 (23–86) 0.02
E 94 (43–124) 106 (57–124) 66 (43–101) NS
vWF (0.42–1.22 IU/ml) A 1.9 (0.47–3.64) 1.91 (0.54–3.21) 1.89 (0.47–3.64) NS
B 0.81 (0.14–2.12) 0.86 (0.36–2.12) 0.64 (0.14–1.94) NS
C 0.9 (0.21–1.7) 0.92 (0.27–1.7) 0.89 (0.21–1.53) NS
D 1.68 (0.8–3.12) 1.59 (0.8–3.12) 2.03 (0.84–2.18) NS
E 2.13 (0.98–3.07) 2.15 (1.72–3.07) 1.73 (0.98–2.72) NS
CRP (,10 mg/l) A 7.7 (0.3–178) 7.4 (2.6–41) 8 (0.3–178) NS
B 4 (0.3–116) 9.4 (0.96–38) 3.4 (0.3–116) NS
C 4.5 (0.3–114) 5.4 (0.96–52) 3.8 (0.3–114) NS
D 127 (42–400) 113 (42–274) 151 (117–400) NS
E 165 (58–400) 154 (58–400) 172 (117–266) NS
vWF ¼ von Willebrand Factor antigen, CRP ¼ C-reactive protein; sample A ¼ immediately prior to the induction of anaesthesia; sample B ¼ immediately before release of the aortic
clamp; sample C ¼ five minutes after aortic clamp release; sample D ¼ 24 h after aortic clamp release; sample E ¼ 48 h after aortic clamp release.
* ¼ Mann–Whitney test.
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Discussion
The present study is the first to examine the
relationship between vWF and PC in patients under-
going ruptured AAA repair. The principal findings of
the study were that circulating vWF levels were
elevated above the normal range in 65% of patients
pre-operatively and almost 90% post-operatively.
Furthermore, there was a significant positive associ-
ation between peri-operative vWF levels and PC, and
between peak vWF levels and the greatest fall in PC
both peri-operatively and during the first 48 h post-
operatively.
Elevated plasma vWF levels are associated with an
increased thrombotic tendency and have been pre-
viously reported in patients with peripheral10 – 12 and
coronary arterial occlusive disease.13 – 15 In patients
undergoing elective reconstruction for non-ruptured
AAA or occlusive disease, Yamazumi et al.9 showed no
difference in pre-operative vWF levels compared with
control patients and Gibbs et al.8 demonstrated an
early post-operative increase in vWF levels in associ-
ation with a procoagulant state. Previous work from
this department has demonstrated ultrastructural
changes in EC morphology consistent with activation
in patients with ruptured AAA.16 Furthermore, a
strong association between pre-operative thrombocy-
topenia and mortality, and immediate post-operative
PC and the development of MOF has been shown in
patients with ruptured AAA6 and similar but less
dramatic changes in PC have been observed after
elective aortic reconstruction for AAA and occlusive
disease.7 The findings of the present study concur with
our previous findings in that peri-operative PC was
significantly lower in non-survivors of rupture.
There was no evidence that haemodilution, dur-
ation of symptoms or pre-operative hypothermia had
an effect on vWF or PC. By contrast, an elevated acute
phase protein response (as demonstrated by elevated
CRP levels) and increased operative blood loss were
associated with reduced peri-operative vWF and PC,
and prolonged aortic clamp time was associated with
reduced PC alone. The negative relationship between
CRP and pre-operative vWF and PC may be due to
thrombus formation and consumption of vWF and PC
occurring earlier during the course of ruptured AAA
in those patients with the most intense acute phase
protein response. One can speculate from these data
that haemorrhagic shock leads to endothelial cell
activation or injury and vWF release. Once circulating
vWF levels are increased, the vWF promotes platelet
binding and initiates the formation of occlusive
platelet thrombi at sites of endothelial injury. vWF
and platelet consumption may occur secondary to
macro- and microvascular thrombus formation and
this, together with increased operative blood loss and
prolonged aortic clamp time, leads to a fall in their
vWF, sample A (IU/ml)
100
 Platelets
 Sample A
  (x 109/l) r = +0.48, p = 0.033
300
200
2.0
400
1.0 3.0 4.0
Fig. 1. vWF against platelet count before operation in 20
patients undergoing ruptured AAA repair.
vWF, sample B (IU/ml)
100
 Platelets
 Sample B
  (x 109/l) r = +0.47, p = 0.044
300
200
2.0
400
1.0 3.0 4.0
Fig. 2. vWF against platelet count immediately before aortic
clamp release in 20 patients undergoing ruptured AAA
repair.
vWF, sample C (IU/ml)
100
 Platelets
 Sample C
  (x 109/l) r = +0.52, p = 0.04
300
200
2.0
400
1.0 3.0 4.0
Fig. 3. vWF against platelet count 5 min after aortic clamp
release in 18 patients undergoing ruptured AAA repair.
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circulating levels. These events may explain the
association between low peri-operative PC and poor
outcome in ruptured AAA repair.
Intravenous desmopressin (DDAVP) leads to an
acute increase in vWF levels with increased platelet
adhesiveness. A randomised trial in patients under-
going elective aortic surgery failed to demonstrate a
significant difference in operative blood loss or
transfusion requirement, or pre- and post-operative
bleeding time, PC or haematocrit.17 DDAVP is also
likely to have limited efficacy in patients with
ruptured AAA as peri-operative vWF levels are
naturally elevated, and the proposed mechanism for
the intra-operative fall in vWF is increased consump-
tion secondary to increased platelet thrombi for-
mation, rather than an actual deficiency of
endogenous vWF activity and/or levels.
In conclusion, these data demonstrate that ruptured
AAA is associated with peri-operative EC activation as
demonstrated by elevated levels of circulating vWF.
EC activation, an elevated acute phase protein
response, increased operative blood loss and pro-
longed aortic clamp time may all contribute to the
peri-operative fall in PC in patients with ruptured
AAA. As vWF promotes platelet aggregation at sites of
endothelial injury, the peri-operative fall in circulating
levels of vWF and PC may represent consumption
secondary to macro- and microvascular thrombus
formation. The resultant procoagulant state may
partly explain the association between low peri-
operative PC and poor outcome in ruptured AAA.
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